Incyte (INCY) Other Working Capital Changes (2010 - 2026)
Incyte (INCY) posted Other Working Capital Changes of -$9.2 million for Q1 2026, up 85.87% on a QoQ basis from -$65.0 million in Q4 2025, and down 114.82% year-over-year from $62.0 million in Q1 2025.
Incyte (INCY) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Incyte's Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$9.2 million for Q1 2026.
- Quarterly Other Working Capital Changes fell 114.82% year-over-year to -$9.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.0 million (up 70.06% YoY) and the FY2025 annual result came in at $156.2 million, up 1607.35% from the prior year.
- Other Working Capital Changes was -$9.2 million for Q1 2026 at Incyte, up from -$65.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $86.4 million in Q2 2025 and bottomed at -$65.7 million in Q4 2024.
- A 5-year average of $12.3 million and a median of $14.0 million in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes plunged 241.42% — and 2025, when it jumped 3554.0%.
- Incyte's Other Working Capital Changes stood at -$9.3 million in 2022, then sank by 111.17% to -$19.6 million in 2023, then sank by 235.61% to -$65.7 million in 2024, then climbed by 1.08% to -$65.0 million in 2025, then jumped by 85.87% to -$9.2 million in 2026.
- Business Quant data shows INCY's Other Working Capital Changes at -$9.2 million in Q1 2026, -$65.0 million in Q4 2025, and $72.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.19 Mn |
| Mar 31, 2026 | -9.19 Mn |
| Mar 31, 2026 | -9.19 Mn |
| Dec 31, 2025 | -65.04 Mn |
| Dec 31, 2025 | -65.04 Mn |
| Dec 31, 2025 | -65.04 Mn |
| Sep 30, 2025 | 72.84 Mn |
| Sep 30, 2025 | 72.84 Mn |
| Sep 30, 2025 | 72.84 Mn |
| Jun 30, 2025 | 86.40 Mn |
| Jun 30, 2025 | 86.40 Mn |
| Jun 30, 2025 | 86.40 Mn |
| Mar 31, 2025 | 62.05 Mn |
| Mar 31, 2025 | 62.05 Mn |
| Mar 31, 2025 | 62.05 Mn |
| Dec 31, 2024 | -65.75 Mn |
| Dec 31, 2024 | -65.75 Mn |
| Dec 31, 2024 | -65.75 Mn |
| Sep 30, 2024 | 15.63 Mn |
| Sep 30, 2024 | 15.63 Mn |